Clinicians
Revolutionary Negative Pressure Therapy
SOMAVAC®: FDA-Cleared Seroma Control.
Improves Outcomes in Breast and Abdominal Wall Surgeries.
Enables drain removal 30% sooner.
50-year-old “technology
SOMAVAC®
Stress-Free Fluid Collection
The SOMAVAC® therapy system replaces outdated manual suction bulbs, streamlines the recovery process, and significantly reduces the incidence of seromas in large flap surgeries. As a clinician, you can rely on SOMAVAC® to simplify recovery and improve patient outcomes.
SOMAVAC® enables drain removal 30% sooner, helping to reduce reoperations and other complications.
Discreet SOMAVAC® therapy helps your patients get up, moving, and back to their lives sooner—because active recovery isn’t just beneficial, it’s essential.
How To Reduce Time With Drains?
Hold Layers Together with Deep Tissue Negative Pressure Therapy
During the inflammatory and proliferative stages of healing, the SOMAVAC® Deep Tissue Negative Pressure Therapy removes fluids, obliterates dead space, and holds layers together. SOMAVAC® is FDA-cleared for seroma prophylaxis.
Continuously Removes Fluid with Smart Suction Technology
In the first few days after surgery, the body can produce over 500cc of fluid, which can slow cell growth and proliferation.*
Representative Drain Output
Our Smart Suction Technology automatically delivers robust, continuous suction to constantly remove fluid and help prevent the formation of complicated or non-resolving seromas.
Drive Patient Compliance with a Clean, Fully Closed System
The clean, fully closed system with one-way drain connectors minimizes the surgical site’s exposure to infectious materials while the patient records fluid amounts and removes and discards fluid. The pump design allows fluid to flow only one way. Meanwhile, the drain connectors’ one-way valve mitigates backflow.
Literature Shows Timely Drain Removal Reduces Infection Risk
Decades of research have shown that continuous suction reduces the incidence of seromas associated with complications. Meanwhile, Olsen et al. (2015) found that strategies that promote the timely removal of drains may reduce the incidence of infection. When drains remain longer than 3 weeks, infection risk can triple. (Hannah et. al. 2016)
Early SOMAVAC® Clinical Results*
The clinical results with SOMAVAC® show that drainage drops below 30cc/24hr in obese patients undergoing mastectomies, and drains can be removed as early as 8.3 days. However, physicians may choose to keep the drains in place longer to provide deep tissue negative pressure therapy in complex reconstructions, immunocompromised patients, and patients with comorbidities.
Due to the constant and effective removal of fluid, surgeons reported using fewer drains per patient with SOMAVAC®.
Less Drain Time
*Data on File
SOMAVAC® is Easy To Use
*In the SOMAVAC® Clinical Study, patients reported that SOMAVAC® was easier to use than an inhaler or thermometer, as reported in the literature.
24/7 Patient Support: +1 (833) 766-2822
At SOMAVAC®, we provide U.S.-based patient support to guide every step of the post-surgical recovery journey. Patients can register their devices for text support and how-to videos or call us anytime for prompt assistance. We’re here to ensure your patients feel supported and cared for around the clock.
